Q32 Bio (QTTB) Return on Capital Employed Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 68,255.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 2,665.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 31,429.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2,503.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -105.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,400.00 |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | 13,039.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,039.00 |
| Dec 31, 2025 | 11,554.00 |
| Sep 30, 2025 | -817.00 |
| Jun 30, 2025 | -3,483.00 |
| Mar 31, 2025 | -577.00 |
| Dec 31, 2024 | -1,990.00 |
| Sep 30, 2024 | -13,569.00 |
| Jun 30, 2024 | -8,617.00 |
| Mar 31, 2024 | -9,857.00 |
| Dec 31, 2023 | -6,033.00 |
| Sep 30, 2023 | 8,107.00 |
| Jun 30, 2023 | 5,098.00 |
| Mar 31, 2023 | 3,861.00 |
| Dec 31, 2022 | 945.00 |
| Sep 30, 2022 | 1,796.00 |
| Jun 30, 2022 | 1,986.00 |
| Mar 31, 2022 | 1,746.00 |
| Dec 31, 2021 | 4,846.00 |
| Sep 30, 2021 | 1,500.00 |
| Jun 30, 2021 | 1,133.00 |
| Mar 31, 2021 | 198.00 |
| Dec 31, 2020 | -2,182.00 |
| Sep 30, 2020 | -2,203.00 |
| Jun 30, 2020 | -1,808.00 |
| Mar 31, 2020 | -1,043.00 |
| Dec 31, 2019 | -1,165.00 |
| Sep 30, 2019 | -1,296.00 |
| Jun 30, 2019 | -994.00 |
| Mar 31, 2019 | -376.00 |